BG Medicine (BGMD) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
BG Medicine Reports 2014 Fourth Quarter and Year End Financial Results
March 31, 2015 7:01 AM EDTNet Loss Reduced by 49% and Operating Cash Burn Cut by 47% From 2013
First Automated Galectin-3 Testing Expected to Launch in U.S. in Mid-2015
WALTHAM, Mass., March 31, 2015 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq: BGMD), the developer of the BGM Galectin-3® Test, today reported financial results for the three months and year ended December 31, 2014.
Full Year 2014... More
